Skip to main content
NCBI home page
Microbiological Reviews logoLink to Microbiological Reviews
. 1996 Jun;60(2):316–341. doi: 10.1128/mr.60.2.316-341.1996

Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis.

B Henderson 1, S Poole 1, M Wilson 1
PMCID: PMC239446  PMID: 8801436

Abstract

Cytokines are a diverse group of proteins and glycoproteins which have potent and wide-ranging effects on eukaryotic cell function and are now recognized as important mediators of tissue pathology in infectious diseases. It is increasingly recognized that for many bacterial species, cytokine induction is a major virulence mechanism. Until recent years, the only bacterial component known to stimulate cytokine synthesis was lipopolysaccharide (LPS). It is only within the past decade that it has been clearly shown that many components associated with the bacterial cell wall, including proteins, glycoproteins, lipoproteins, carbohydrates, and lipids, have the capacity to stimulate mammalian cells to produce a diverse array of cytokines. It has been established that many of these cytokine-inducing molecules act by mechanisms distinct from that of LPS, and thus their activities are not due to LPS contamination. Bacteria produce a wide range of virulence factors which cause host tissue pathology, and these diverse factors have been grouped into four families: adhesins, aggressins, impedins, and invasins. We suggest that the array of bacterial cytokine-inducing molecules represents a new class of bacterial virulence factor, and, by analogy with the known virulence families, we suggest the term "modulin" to describe these molecules, because the action of cytokines is to modulate eukaryotic cell behavior. This review summarizes our current understanding of cytokine biology in relation to tissue homeostasis and disease and concisely reviews the current literature on the cytokine-inducing molecules produced by gram-negative and gram-positive bacteria, with an emphasis on the cellular mechanisms responsible for cytokine induction. We propose that modulins, by controlling the host immune and inflammatory responses, maintain the large commensal flora that all multicellular organisms support.

Full Text

The Full Text of this article is available as a PDF (516.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams L. B., Fukutomi Y., Krahenbuhl J. L. Regulation of murine macrophage effector functions by lipoarabinomannan from mycobacterial strains with different degrees of virulence. Infect Immun. 1993 Oct;61(10):4173–4181. doi: 10.1128/iai.61.10.4173-4181.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barber S. A., Perera P. Y., Vogel S. N. Defective ceramide response in C3H/HeJ (Lpsd) macrophages. J Immunol. 1995 Sep 1;155(5):2303–2305. [PubMed] [Google Scholar]
  3. Barnes P. F., Chatterjee D., Abrams J. S., Lu S., Wang E., Yamamura M., Brennan P. J., Modlin R. L. Cytokine production induced by Mycobacterium tuberculosis lipoarabinomannan. Relationship to chemical structure. J Immunol. 1992 Jul 15;149(2):541–547. [PubMed] [Google Scholar]
  4. Beagley K. W., Fujihashi K., Black C. A., Lagoo A. S., Yamamoto M., McGhee J. R., Kiyono H. The Mycobacterium tuberculosis 71-kDa heat-shock protein induces proliferation and cytokine secretion by murine gut intraepithelial lymphocytes. Eur J Immunol. 1993 Aug;23(8):2049–2052. doi: 10.1002/eji.1830230852. [DOI] [PubMed] [Google Scholar]
  5. Beezhold D. H., Best G. K., Bonventre P. F., Thompson M. Synergistic induction of interleukin-1 by endotoxin and toxic shock syndrome toxin-1 using rat macrophages. Infect Immun. 1987 Dec;55(12):2865–2869. doi: 10.1128/iai.55.12.2865-2869.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Betley M. J., Borst D. W., Regassa L. B. Staphylococcal enterotoxins, toxic shock syndrome toxin and streptococcal pyrogenic exotoxins: a comparative study of their molecular biology. Chem Immunol. 1992;55:1–35. [PubMed] [Google Scholar]
  7. Bhakdi S., Klonisch T., Nuber P., Fischer W. Stimulation of monokine production by lipoteichoic acids. Infect Immun. 1991 Dec;59(12):4614–4620. doi: 10.1128/iai.59.12.4614-4620.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bhakdi S., Muhly M., Korom S., Hugo F. Release of interleukin-1 beta associated with potent cytocidal action of staphylococcal alpha-toxin on human monocytes. Infect Immun. 1989 Nov;57(11):3512–3519. doi: 10.1128/iai.57.11.3512-3519.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Bhakdi S., Muhly M., Korom S., Schmidt G. Effects of Escherichia coli hemolysin on human monocytes. Cytocidal action and stimulation of interleukin 1 release. J Clin Invest. 1990 Jun;85(6):1746–1753. doi: 10.1172/JCI114631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Bjornson B. H., Agura E., Harvey J. M., Johns M., Andrews R. G., McCabe W. R. Endotoxin-associated protein: a potent stimulus for human granulocytopoietic activity which may be accessory cell independent. Infect Immun. 1988 Jun;56(6):1602–1607. doi: 10.1128/iai.56.6.1602-1607.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Blondiau C., Lagadec P., Lejeune P., Onier N., Cavaillon J. M., Jeannin J. F. Correlation between the capacity to activate macrophages in vitro and the antitumor activity in vivo of lipopolysaccharides from different bacterial species. Immunobiology. 1994 Apr;190(3):243–254. doi: 10.1016/S0171-2985(11)80272-X. [DOI] [PubMed] [Google Scholar]
  12. Brandon E. P., Idzerda R. L., McKnight G. S. Knockouts. Targeting the mouse genome: a compendium of knockouts (Part I) Curr Biol. 1995 Jun 1;5(6):625–634. doi: 10.1016/s0960-9822(95)00127-8. [DOI] [PubMed] [Google Scholar]
  13. Brett S. J., Mazurov A. V., Charles I. G., Tite J. P. The invasin protein of Yersinia spp. provides co-stimulatory activity to human T cells through interaction with beta 1 integrins. Eur J Immunol. 1993 Jul;23(7):1608–1614. doi: 10.1002/eji.1830230732. [DOI] [PubMed] [Google Scholar]
  14. Cavaillon J. M., Haeffner-Cavaillon N. Signals involved in interleukin 1 synthesis and release by lipopolysaccharide-stimulated monocytes/macrophages. Cytokine. 1990 Sep;2(5):313–329. doi: 10.1016/1043-4666(90)90061-w. [DOI] [PubMed] [Google Scholar]
  15. Chan J., Fan X. D., Hunter S. W., Brennan P. J., Bloom B. R. Lipoarabinomannan, a possible virulence factor involved in persistence of Mycobacterium tuberculosis within macrophages. Infect Immun. 1991 May;59(5):1755–1761. doi: 10.1128/iai.59.5.1755-1761.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Chedid L. Muramyl peptides as possible endogenous immunopharmacological mediators. Microbiol Immunol. 1983;27(9):723–732. doi: 10.1111/j.1348-0421.1983.tb00636.x. [DOI] [PubMed] [Google Scholar]
  17. Chernoff A. E., Granowitz E. V., Shapiro L., Vannier E., Lonnemann G., Angel J. B., Kennedy J. S., Rabson A. R., Wolff S. M., Dinarello C. A. A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses. J Immunol. 1995 May 15;154(10):5492–5499. [PubMed] [Google Scholar]
  18. Christ W. J., Asano O., Robidoux A. L., Perez M., Wang Y., Dubuc G. R., Gavin W. E., Hawkins L. D., McGuinness P. D., Mullarkey M. A. E5531, a pure endotoxin antagonist of high potency. Science. 1995 Apr 7;268(5207):80–83. doi: 10.1126/science.7701344. [DOI] [PubMed] [Google Scholar]
  19. Coffey R. G., Weakland L. L., Alberts V. A. Paradoxical stimulation and inhibition by protein kinase C modulating agents of lipopolysaccharide evoked production of tumour necrosis factor in human monocytes. Immunology. 1992 May;76(1):48–54. [PMC free article] [PubMed] [Google Scholar]
  20. Cohen J. J., Duke R. C., Fadok V. A., Sellins K. S. Apoptosis and programmed cell death in immunity. Annu Rev Immunol. 1992;10:267–293. doi: 10.1146/annurev.iy.10.040192.001411. [DOI] [PubMed] [Google Scholar]
  21. Cosman D. The hematopoietin receptor superfamily. Cytokine. 1993 Mar;5(2):95–106. doi: 10.1016/1043-4666(93)90047-9. [DOI] [PubMed] [Google Scholar]
  22. Czarny A., Witkowska D., Mulczyk M. Induction of tumor necrosis factor and interleukin 6 by outer membrane proteins of Shigella in spleen cells and macrophages of mice. Arch Immunol Ther Exp (Warsz) 1993;41(2):153–157. [PubMed] [Google Scholar]
  23. Daley L., Pier G. B., Liporace J. D., Eardley D. D. Polyclonal B cell stimulation and interleukin 1 induction by the mucoid exopolysaccharide of Pseudomonas aeruginosa associated with cystic fibrosis. J Immunol. 1985 May;134(5):3089–3093. [PubMed] [Google Scholar]
  24. Dalton D. K., Pitts-Meek S., Keshav S., Figari I. S., Bradley A., Stewart T. A. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science. 1993 Mar 19;259(5102):1739–1742. doi: 10.1126/science.8456300. [DOI] [PubMed] [Google Scholar]
  25. Danforth J. M., Strieter R. M., Kunkel S. L., Arenberg D. A., VanOtteren G. M., Standiford T. J. Macrophage inflammatory protein-1 alpha expression in vivo and in vitro: the role of lipoteichoic acid. Clin Immunol Immunopathol. 1995 Jan;74(1):77–83. doi: 10.1006/clin.1995.1011. [DOI] [PubMed] [Google Scholar]
  26. Danner R. L., Joiner K. A., Parrillo J. E. Inhibition of endotoxin-induced priming of human neutrophils by lipid X and 3-Aza-lipid X. J Clin Invest. 1987 Sep;80(3):605–612. doi: 10.1172/JCI113112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Del Prete G. F., De Carli M., Mastromauro C., Biagiotti R., Macchia D., Falagiani P., Ricci M., Romagnani S. Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. J Clin Invest. 1991 Jul;88(1):346–350. doi: 10.1172/JCI115300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Denis M., Campbell D., Gregg E. O. Cytokine stimulation of parasitic and microbial growth. Res Microbiol. 1991 Nov-Dec;142(9):979–983. doi: 10.1016/0923-2508(91)90008-x. [DOI] [PubMed] [Google Scholar]
  29. Denis M., Campbell D., Gregg E. O. Interleukin-2 and granulocyte-macrophage colony-stimulating factor stimulate growth of a virulent strain of Escherichia coli. Infect Immun. 1991 May;59(5):1853–1856. doi: 10.1128/iai.59.5.1853-1856.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Denis M. Growth of Mycobacterium avium in human monocytes: identification of cytokines which reduce and enhance intracellular microbial growth. Eur J Immunol. 1991 Feb;21(2):391–395. doi: 10.1002/eji.1830210221. [DOI] [PubMed] [Google Scholar]
  31. Dinarello C. A. Interleukin-1. Adv Pharmacol. 1994;25:21–51. doi: 10.1016/s1054-3589(08)60429-9. [DOI] [PubMed] [Google Scholar]
  32. Dinarello C. A., Krueger J. M. Induction of interleukin 1 by synthetic and naturally occurring muramyl peptides. Fed Proc. 1986 Oct;45(11):2545–2548. [PubMed] [Google Scholar]
  33. Dokter W. H., Dijkstra A. J., Koopmans S. B., Mulder A. B., Stulp B. K., Halie M. R., Keck W., Vellenga E. G(AnH)MTetra, a naturally occurring 1,6-anhydro muramyl dipeptide, induces granulocyte colony-stimulating factor expression in human monocytes: a molecular analysis. Infect Immun. 1994 Jul;62(7):2953–2957. doi: 10.1128/iai.62.7.2953-2957.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Dokter W. H., Dijkstra A. J., Koopmans S. B., Stulp B. K., Keck W., Halie M. R., Vellenga E. G(Anh)MTetra, a natural bacterial cell wall breakdown product, induces interleukin-1 beta and interleukin-6 expression in human monocytes. A study of the molecular mechanisms involved in inflammatory cytokine expression. J Biol Chem. 1994 Feb 11;269(6):4201–4206. [PubMed] [Google Scholar]
  35. Dong Z., Qi X., Fidler I. J. Tyrosine phosphorylation of mitogen-activated protein kinases is necessary for activation of murine macrophages by natural and synthetic bacterial products. J Exp Med. 1993 Apr 1;177(4):1071–1077. doi: 10.1084/jem.177.4.1071. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Dziarski R. Cell-bound albumin is the 70-kDa peptidoglycan-, lipopolysaccharide-, and lipoteichoic acid-binding protein on lymphocytes and macrophages. J Biol Chem. 1994 Aug 12;269(32):20431–20436. [PubMed] [Google Scholar]
  37. Dziarski R. Demonstration of peptidoglycan-binding sites on lymphocytes and macrophages by photoaffinity cross-linking. J Biol Chem. 1991 Mar 15;266(8):4713–4718. [PubMed] [Google Scholar]
  38. Dziarski R., Gupta D. Heparin, sulfated heparinoids, and lipoteichoic acids bind to the 70-kDa peptidoglycan/lipopolysaccharide receptor protein on lymphocytes. J Biol Chem. 1994 Jan 21;269(3):2100–2110. [PubMed] [Google Scholar]
  39. Dziarski R. Peptidoglycan and lipopolysaccharide bind to the same binding site on lymphocytes. J Biol Chem. 1991 Mar 15;266(8):4719–4725. [PubMed] [Google Scholar]
  40. Eckmann L., Kagnoff M. F., Fierer J. Epithelial cells secrete the chemokine interleukin-8 in response to bacterial entry. Infect Immun. 1993 Nov;61(11):4569–4574. doi: 10.1128/iai.61.11.4569-4574.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Eisenberg S. P., Evans R. J., Arend W. P., Verderber E., Brewer M. T., Hannum C. H., Thompson R. C. Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature. 1990 Jan 25;343(6256):341–346. doi: 10.1038/343341a0. [DOI] [PubMed] [Google Scholar]
  42. Elsbach P., Weiss J. Bactericidal/permeability increasing protein and host defense against gram-negative bacteria and endotoxin. Curr Opin Immunol. 1993 Feb;5(1):103–107. doi: 10.1016/0952-7915(93)90088-a. [DOI] [PubMed] [Google Scholar]
  43. Evans D. J., Jr, Evans D. G., Takemura T., Nakano H., Lampert H. C., Graham D. Y., Granger D. N., Kvietys P. R. Characterization of a Helicobacter pylori neutrophil-activating protein. Infect Immun. 1995 Jun;63(6):2213–2220. doi: 10.1128/iai.63.6.2213-2220.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Fagan M. A., Liu Y., Stütz P., Vyplel H., Golenbock D. T. Acyclic analogue of lipid A stimulates TNF-alpha and arachidonate release via a unique LPS-signaling pathway. J Immunol. 1994 Dec 1;153(11):5230–5238. [PubMed] [Google Scholar]
  45. Fearns C., Kravchenko V. V., Ulevitch R. J., Loskutoff D. J. Murine CD14 gene expression in vivo: extramyeloid synthesis and regulation by lipopolysaccharide. J Exp Med. 1995 Mar 1;181(3):857–866. doi: 10.1084/jem.181.3.857. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Feist W., Ulmer A. J., Musehold J., Brade H., Kusumoto S., Flad H. D. Induction of tumor necrosis factor-alpha release by lipopolysaccharide and defined lipopolysaccharide partial structures. Immunobiology. 1989 Oct;179(4-5):293–307. doi: 10.1016/S0171-2985(89)80036-1. [DOI] [PubMed] [Google Scholar]
  47. Ferrero E., Jiao D., Tsuberi B. Z., Tesio L., Rong G. W., Haziot A., Goyert S. M. Transgenic mice expressing human CD14 are hypersensitive to lipopolysaccharide. Proc Natl Acad Sci U S A. 1993 Mar 15;90(6):2380–2384. doi: 10.1073/pnas.90.6.2380. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Fiers W., Brouckaert P., Goldberg A. L., Kettelhut I., Suffys P., Tavernier J., Vanhaesebroeck B., Van Roy F. Structure-function relationship of tumour necrosis factor and its mechanism of action. Ciba Found Symp. 1987;131:109–123. doi: 10.1002/9780470513521.ch8. [DOI] [PubMed] [Google Scholar]
  49. Flegel W. A., Müller F., Däubener W., Fischer H. G., Hadding U., Northoff H. Cytokine response by human monocytes to Clostridium difficile toxin A and toxin B. Infect Immun. 1991 Oct;59(10):3659–3666. doi: 10.1128/iai.59.10.3659-3666.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Friedland J. S., Shattock R., Remick D. G., Griffin G. E. Mycobacterial 65-kD heat shock protein induces release of proinflammatory cytokines from human monocytic cells. Clin Exp Immunol. 1993 Jan;91(1):58–62. doi: 10.1111/j.1365-2249.1993.tb03354.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Fuleihan R., Mourad W., Geha R. S., Chatila T. Engagement of MHC-class II molecules by staphylococcal exotoxins delivers a comitogenic signal to human B cells. J Immunol. 1991 Mar 1;146(5):1661–1666. [PubMed] [Google Scholar]
  52. Galdiero F., Sommese L., Scarfogliero P., Galdiero M. Biological activities--lethality, Shwartzman reaction and pyrogenicity--of Salmonella typhimurium porins. Microb Pathog. 1994 Feb;16(2):111–119. doi: 10.1006/mpat.1994.1012. [DOI] [PubMed] [Google Scholar]
  53. Galdiero F., Tufano M. A., Galdiero M., Masiello S., Di Rosa M. Inflammatory effects of Salmonella typhimurium porins. Infect Immun. 1990 Oct;58(10):3183–3186. doi: 10.1128/iai.58.10.3183-3186.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Galdiero F., de L'ero G. C., Benedetto N., Galdiero M., Tufano M. A. Release of cytokines induced by Salmonella typhimurium porins. Infect Immun. 1993 Jan;61(1):155–161. doi: 10.1128/iai.61.1.155-161.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Galán J. E., Pace J., Hayman M. J. Involvement of the epidermal growth factor receptor in the invasion of cultured mammalian cells by Salmonella typhimurium. Nature. 1992 Jun 18;357(6379):588–589. doi: 10.1038/357588a0. [DOI] [PubMed] [Google Scholar]
  56. Gol-Winkler R. Paracrine action of transforming growth factors. Clin Endocrinol Metab. 1986 Feb;15(1):99–115. doi: 10.1016/s0300-595x(86)80044-5. [DOI] [PubMed] [Google Scholar]
  57. Gooding L. R. Virus proteins that counteract host immune defenses. Cell. 1992 Oct 2;71(1):5–7. doi: 10.1016/0092-8674(92)90259-f. [DOI] [PubMed] [Google Scholar]
  58. Goodman G. W., Sultzer B. M. Endotoxin protein is a mitogen and polyclonal activator of human B lymphocytes. J Exp Med. 1979 Mar 1;149(3):713–723. doi: 10.1084/jem.149.3.713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Gray P. W., Flaggs G., Leong S. R., Gumina R. J., Weiss J., Ooi C. E., Elsbach P. Cloning of the cDNA of a human neutrophil bactericidal protein. Structural and functional correlations. J Biol Chem. 1989 Jun 5;264(16):9505–9509. [PubMed] [Google Scholar]
  60. Grimminger F., Sibelius U., Bhakdi S., Suttorp N., Seeger W. Escherichia coli hemolysin is a potent inductor of phosphoinositide hydrolysis and related metabolic responses in human neutrophils. J Clin Invest. 1991 Nov;88(5):1531–1539. doi: 10.1172/JCI115463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Grossman D., Lamphear J. G., Mollick J. A., Betley M. J., Rich R. R. Dual roles for class II major histocompatibility complex molecules in staphylococcal enterotoxin-induced cytokine production and in vivo toxicity. Infect Immun. 1992 Dec;60(12):5190–5196. doi: 10.1128/iai.60.12.5190-5196.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Grunwald U., Krüger C., Westermann J., Lukowsky A., Ehlers M., Schütt C. An enzyme-linked immunosorbent assay for the quantification of solubilized CD14 in biological fluids. J Immunol Methods. 1992 Nov 5;155(2):225–232. doi: 10.1016/0022-1759(92)90289-6. [DOI] [PubMed] [Google Scholar]
  63. Haeffner-Cavaillon N., Caroff M., Cavaillon J. M. Interleukin-1 induction by lipopolysaccharides: structural requirements of the 3-deoxy-D-manno-2-octulosonic acid (KDO). Mol Immunol. 1989 May;26(5):485–494. doi: 10.1016/0161-5890(89)90108-9. [DOI] [PubMed] [Google Scholar]
  64. Haeffner-Cavaillon N., Cavaillon J. M., Moreau M., Szabó L. Interleukin 1 secretion by human monocytes stimulated by the isolated polysaccharide region of the Bordetella pertussis endotoxin. Mol Immunol. 1984 May;21(5):389–395. doi: 10.1016/0161-5890(84)90036-1. [DOI] [PubMed] [Google Scholar]
  65. Hailman E., Lichenstein H. S., Wurfel M. M., Miller D. S., Johnson D. A., Kelley M., Busse L. A., Zukowski M. M., Wright S. D. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J Exp Med. 1994 Jan 1;179(1):269–277. doi: 10.1084/jem.179.1.269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Hanazawa S., Murakami Y., Hirose K., Amano S., Ohmori Y., Higuchi H., Kitano S. Bacteroides (Porphyromonas) gingivalis fimbriae activate mouse peritoneal macrophages and induce gene expression and production of interleukin-1. Infect Immun. 1991 Jun;59(6):1972–1977. doi: 10.1128/iai.59.6.1972-1977.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Hannum C. H., Wilcox C. J., Arend W. P., Joslin F. G., Dripps D. J., Heimdal P. L., Armes L. G., Sommer A., Eisenberg S. P., Thompson R. C. Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature. 1990 Jan 25;343(6256):336–340. doi: 10.1038/343336a0. [DOI] [PubMed] [Google Scholar]
  68. Harvey W., Kamin S., Meghji S., Wilson M. Interleukin-1-like activity in capsular material from Haemophilus actinomycetemcomitans. Immunology. 1987 Mar;60(3):415–418. [PMC free article] [PubMed] [Google Scholar]
  69. Hauschildt S., Hoffmann P., Beuscher H. U., Dufhues G., Heinrich P., Wiesmüller K. H., Jung G., Bessler W. G. Activation of bone marrow-derived mouse macrophages by bacterial lipopeptide: cytokine production, phagocytosis and Ia expression. Eur J Immunol. 1990 Jan;20(1):63–68. doi: 10.1002/eji.1830200110. [DOI] [PubMed] [Google Scholar]
  70. Haziot A., Rong G. W., Bazil V., Silver J., Goyert S. M. Recombinant soluble CD14 inhibits LPS-induced tumor necrosis factor-alpha production by cells in whole blood. J Immunol. 1994 Jun 15;152(12):5868–5876. [PubMed] [Google Scholar]
  71. Haziot A., Rong G. W., Silver J., Goyert S. M. Recombinant soluble CD14 mediates the activation of endothelial cells by lipopolysaccharide. J Immunol. 1993 Aug 1;151(3):1500–1507. [PubMed] [Google Scholar]
  72. Hedges S., Svensson M., Svanborg C. Interleukin-6 response of epithelial cell lines to bacterial stimulation in vitro. Infect Immun. 1992 Apr;60(4):1295–1301. doi: 10.1128/iai.60.4.1295-1301.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Heiss L. N., Moser S. A., Unanue E. R., Goldman W. E. Interleukin-1 is linked to the respiratory epithelial cytopathology of pertussis. Infect Immun. 1993 Aug;61(8):3123–3128. doi: 10.1128/iai.61.8.3123-3128.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Henderson B., Pettipher E. R., Higgs G. A. Mediators of rheumatoid arthritis. Br Med Bull. 1987 Apr;43(2):415–428. doi: 10.1093/oxfordjournals.bmb.a072191. [DOI] [PubMed] [Google Scholar]
  75. Henderson B., Poole S. Modulation of cytokine function: therapeutic applications. Adv Pharmacol. 1994;25:53–115. doi: 10.1016/s1054-3589(08)60430-5. [DOI] [PubMed] [Google Scholar]
  76. Henderson B. Therapeutic modulation of cytokines. Ann Rheum Dis. 1995 Jun;54(6):519–523. doi: 10.1136/ard.54.6.519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Henne E., Campbell W. H., Carlson E. Toxic shock syndrome toxin 1 enhances synthesis of endotoxin-induced tumor necrosis factor in mice. Infect Immun. 1991 Sep;59(9):2929–2933. doi: 10.1128/iai.59.9.2929-2933.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Herbelin A., Ruuth E., Delorme D., Michel-Herbelin C., Praz F. Mycoplasma arginini TUH-14 membrane lipoproteins induce production of interleukin-1, interleukin-6, and tumor necrosis factor alpha by human monocytes. Infect Immun. 1994 Oct;62(10):4690–4694. doi: 10.1128/iai.62.10.4690-4694.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Hess C. B., Niesel D. W., Cho Y. J., Klimpel G. R. Bacterial invasion of fibroblasts induces interferon production. J Immunol. 1987 Jun 1;138(11):3949–3953. [PubMed] [Google Scholar]
  80. Heumann D., Barras C., Severin A., Glauser M. P., Tomasz A. Gram-positive cell walls stimulate synthesis of tumor necrosis factor alpha and interleukin-6 by human monocytes. Infect Immun. 1994 Jul;62(7):2715–2721. doi: 10.1128/iai.62.7.2715-2721.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Hitchcock P. J., Leive L., Mäkelä P. H., Rietschel E. T., Strittmatter W., Morrison D. C. Lipopolysaccharide nomenclature--past, present, and future. J Bacteriol. 1986 Jun;166(3):699–705. doi: 10.1128/jb.166.3.699-705.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Hogan M. M., Vogel S. N. Lipid A-associated proteins provide an alternate "second signal" in the activation of recombinant interferon-gamma-primed, C3H/HeJ macrophages to a fully tumoricidal state. J Immunol. 1987 Dec 1;139(11):3697–3702. [PubMed] [Google Scholar]
  83. Hoover D. L., Friedlander A. M., Rogers L. C., Yoon I. K., Warren R. L., Cross A. S. Anthrax edema toxin differentially regulates lipopolysaccharide-induced monocyte production of tumor necrosis factor alpha and interleukin-6 by increasing intracellular cyclic AMP. Infect Immun. 1994 Oct;62(10):4432–4439. doi: 10.1128/iai.62.10.4432-4439.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Houldsworth S., Andrew P. W., Mitchell T. J. Pneumolysin stimulates production of tumor necrosis factor alpha and interleukin-1 beta by human mononuclear phagocytes. Infect Immun. 1994 Apr;62(4):1501–1503. doi: 10.1128/iai.62.4.1501-1503.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Hsu D. H., de Waal Malefyt R., Fiorentino D. F., Dang M. N., Vieira P., de Vries J., Spits H., Mosmann T. R., Moore K. W. Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1. Science. 1990 Nov 9;250(4982):830–832. doi: 10.1126/science.2173142. [DOI] [PubMed] [Google Scholar]
  86. Huang J., O'Toole P. W., Doig P., Trust T. J. Stimulation of interleukin-8 production in epithelial cell lines by Helicobacter pylori. Infect Immun. 1995 May;63(5):1732–1738. doi: 10.1128/iai.63.5.1732-1738.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Ingalls R. R., Golenbock D. T. CD11c/CD18, a transmembrane signaling receptor for lipopolysaccharide. J Exp Med. 1995 Apr 1;181(4):1473–1479. doi: 10.1084/jem.181.4.1473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Jakway J. P., DeFranco A. L. Pertussis toxin inhibition of B cell and macrophage responses to bacterial lipopolysaccharide. Science. 1986 Nov 7;234(4777):743–746. doi: 10.1126/science.3095921. [DOI] [PubMed] [Google Scholar]
  89. Johns M. A., Sipe J. D., Melton L. B., Strom T. B., McCabe W. R. Endotoxin-associated protein: interleukin-1-like activity on serum amyloid A synthesis and T-lymphocyte activation. Infect Immun. 1988 Jun;56(6):1593–1601. doi: 10.1128/iai.56.6.1593-1601.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Joseph C. K., Wright S. D., Bornmann W. G., Randolph J. T., Kumar E. R., Bittman R., Liu J., Kolesnick R. N. Bacterial lipopolysaccharide has structural similarity to ceramide and stimulates ceramide-activated protein kinase in myeloid cells. J Biol Chem. 1994 Jul 1;269(26):17606–17610. [PubMed] [Google Scholar]
  91. Just I., Selzer J., Wilm M., von Eichel-Streiber C., Mann M., Aktories K. Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature. 1995 Jun 8;375(6531):500–503. doi: 10.1038/375500a0. [DOI] [PubMed] [Google Scholar]
  92. Kapur V., Majesky M. W., Li L. L., Black R. A., Musser J. M. Cleavage of interleukin 1 beta (IL-1 beta) precursor to produce active IL-1 beta by a conserved extracellular cysteine protease from Streptococcus pyogenes. Proc Natl Acad Sci U S A. 1993 Aug 15;90(16):7676–7680. doi: 10.1073/pnas.90.16.7676. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Kawata Y., Hanazawa S., Amano S., Murakami Y., Matsumoto T., Nishida K., Kitano S. Porphyromonas gingivalis fimbriae stimulate bone resorption in vitro. Infect Immun. 1994 Jul;62(7):3012–3016. doi: 10.1128/iai.62.7.3012-3016.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  94. Keller R., Fischer W., Keist R., Bassetti S. Macrophage response to bacteria: induction of marked secretory and cellular activities by lipoteichoic acids. Infect Immun. 1992 Sep;60(9):3664–3672. doi: 10.1128/iai.60.9.3664-3672.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Kharazmi A. Mechanisms involved in the evasion of the host defence by Pseudomonas aeruginosa. Immunol Lett. 1991 Oct;30(2):201–205. doi: 10.1016/0165-2478(91)90026-7. [DOI] [PubMed] [Google Scholar]
  96. Killion J. W., Morrison D. C. Protection of C3H/HeJ mice from lethal Salmonella typhimurium LT2 infection by immunization with lipopolysaccharide-lipid A-associated protein complexes. Infect Immun. 1986 Oct;54(1):1–8. doi: 10.1128/iai.54.1.1-8.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  97. Kim K. S., Le J. IL-1 beta and Escherichia coli. Science. 1992 Dec 4;258(5088):1562–1563. doi: 10.1126/science.1455239. [DOI] [PubMed] [Google Scholar]
  98. Kirkland T. N., Finley F., Leturcq D., Moriarty A., Lee J. D., Ulevitch R. J., Tobias P. S. Analysis of lipopolysaccharide binding by CD14. J Biol Chem. 1993 Nov 25;268(33):24818–24823. [PubMed] [Google Scholar]
  99. Kishimoto T. K., Rothlein R. Integrins, ICAMs, and selectins: role and regulation of adhesion molecules in neutrophil recruitment to inflammatory sites. Adv Pharmacol. 1994;25:117–169. doi: 10.1016/s1054-3589(08)60431-7. [DOI] [PubMed] [Google Scholar]
  100. Kishimoto T., Akira S., Taga T. Interleukin-6 and its receptor: a paradigm for cytokines. Science. 1992 Oct 23;258(5082):593–597. doi: 10.1126/science.1411569. [DOI] [PubMed] [Google Scholar]
  101. Kjeldsen M., Holmstrup P., Bendtzen K. Marginal periodontitis and cytokines: a review of the literature. J Periodontol. 1993 Nov;64(11):1013–1022. doi: 10.1902/jop.1993.64.11.1013. [DOI] [PubMed] [Google Scholar]
  102. Klapproth J. M., Donnenberg M. S., Abraham J. M., Mobley H. L., James S. P. Products of enteropathogenic Escherichia coli inhibit lymphocyte activation and lymphokine production. Infect Immun. 1995 Jun;63(6):2248–2254. doi: 10.1128/iai.63.6.2248-2254.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  103. Korn A., Kroll H. P., Berger H. P., Kahler A., Hessler R., Brauburger J., Müller K. P., Nixdorff K. The 39-kilodalton outer membrane protein of Proteus mirabilis is an OmpA protein and mitogen for murine B lymphocytes. Infect Immun. 1993 Nov;61(11):4915–4918. doi: 10.1128/iai.61.11.4915-4918.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  104. Kostyal D. A., Butler G. H., Beezhold D. H. A 48-kilodalton Mycoplasma fermentans membrane protein induces cytokine secretion by human monocytes. Infect Immun. 1994 Sep;62(9):3793–3800. doi: 10.1128/iai.62.9.3793-3800.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  105. Krebs E. G. The growth of research on protein phosphorylation. Trends Biochem Sci. 1994 Nov;19(11):439–439. doi: 10.1016/0968-0004(94)90125-2. [DOI] [PubMed] [Google Scholar]
  106. Kreft B., Bohnet S., Carstensen O., Hacker J., Marre R. Differential expression of interleukin-6, intracellular adhesion molecule 1, and major histocompatibility complex class II molecules in renal carcinoma cells stimulated with S fimbriae of uropathogenic Escherichia coli. Infect Immun. 1993 Jul;61(7):3060–3063. doi: 10.1128/iai.61.7.3060-3063.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. König B., Ludwig A., Goebel W., König W. Pore formation by the Escherichia coli alpha-hemolysin: role for mediator release from human inflammatory cells. Infect Immun. 1994 Oct;62(10):4611–4617. doi: 10.1128/iai.62.10.4611-4617.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Kühn R., Löhler J., Rennick D., Rajewsky K., Müller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 1993 Oct 22;75(2):263–274. doi: 10.1016/0092-8674(93)80068-p. [DOI] [PubMed] [Google Scholar]
  109. Le Contel C., Temime N., Charron D. J., Parant M. A. Modulation of lipopolysaccharide-induced cytokine gene expression in mouse bone marrow-derived macrophages by muramyl dipeptide. J Immunol. 1993 May 15;150(10):4541–4549. [PubMed] [Google Scholar]
  110. Lebbar S., Cavaillon J. M., Caroff M., Ledur A., Brade H., Sarfati R., Haeffner-Cavaillon N. Molecular requirement for interleukin 1 induction by lipopolysaccharide-stimulated human monocytes: involvement of the heptosyl-2-keto-3-deoxyoctulosonate region. Eur J Immunol. 1986 Jan;16(1):87–91. doi: 10.1002/eji.1830160117. [DOI] [PubMed] [Google Scholar]
  111. Lee A., Fox J., Hazell S. Pathogenicity of Helicobacter pylori: a perspective. Infect Immun. 1993 May;61(5):1601–1610. doi: 10.1128/iai.61.5.1601-1610.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  112. Lee J. D., Kravchenko V., Kirkland T. N., Han J., Mackman N., Moriarty A., Leturcq D., Tobias P. S., Ulevitch R. J. Glycosyl-phosphatidylinositol-anchored or integral membrane forms of CD14 mediate identical cellular responses to endotoxin. Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):9930–9934. doi: 10.1073/pnas.90.21.9930. [DOI] [PMC free article] [PubMed] [Google Scholar]
  113. Legaard P. K., LeGrand R. D., Misfeldt M. L. The superantigen Pseudomonas exotoxin A requires additional functions from accessory cells for T lymphocyte proliferation. Cell Immunol. 1991 Jul;135(2):372–382. doi: 10.1016/0008-8749(91)90282-g. [DOI] [PubMed] [Google Scholar]
  114. Lei M. G., Morrison D. C. Specific endotoxic lipopolysaccharide-binding proteins on murine splenocytes. I. Detection of lipopolysaccharide-binding sites on splenocytes and splenocyte subpopulations. J Immunol. 1988 Aug 1;141(3):996–1005. [PubMed] [Google Scholar]
  115. Lei M. G., Morrison D. C. Specific endotoxic lipopolysaccharide-binding proteins on murine splenocytes. II. Membrane localization and binding characteristics. J Immunol. 1988 Aug 1;141(3):1006–1011. [PubMed] [Google Scholar]
  116. Lei M. G., Stimpson S. A., Morrison D. C. Specific endotoxic lipopolysaccharide-binding receptors on murine splenocytes. III. Binding specificity and characterization. J Immunol. 1991 Sep 15;147(6):1925–1932. [PubMed] [Google Scholar]
  117. Leung D. Y., Gately M., Trumble A., Ferguson-Darnell B., Schlievert P. M., Picker L. J. Bacterial superantigens induce T cell expression of the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen, via stimulation of interleukin 12 production. J Exp Med. 1995 Feb 1;181(2):747–753. doi: 10.1084/jem.181.2.747. [DOI] [PMC free article] [PubMed] [Google Scholar]
  118. Li P., Allen H., Banerjee S., Franklin S., Herzog L., Johnston C., McDowell J., Paskind M., Rodman L., Salfeld J. Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock. Cell. 1995 Feb 10;80(3):401–411. doi: 10.1016/0092-8674(95)90490-5. [DOI] [PubMed] [Google Scholar]
  119. Lichtman S. N., Wang J., Schwab J. H., Lemasters J. J. Comparison of peptidoglycan-polysaccharide and lipopolysaccharide stimulation of Kupffer cells to produce tumor necrosis factor and interleukin-1. Hepatology. 1994 Apr;19(4):1013–1022. [PubMed] [Google Scholar]
  120. Linder H., Engberg I., Hoschützky H., Mattsby-Baltzer I., Svanborg C. Adhesion-dependent activation of mucosal interleukin-6 production. Infect Immun. 1991 Dec;59(12):4357–4362. doi: 10.1128/iai.59.12.4357-4362.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  121. Loppnow H., Brade H., Dürrbaum I., Dinarello C. A., Kusumoto S., Rietschel E. T., Flad H. D. IL-1 induction-capacity of defined lipopolysaccharide partial structures. J Immunol. 1989 May 1;142(9):3229–3238. [PubMed] [Google Scholar]
  122. Luetteke N. C., Qiu T. H., Peiffer R. L., Oliver P., Smithies O., Lee D. C. TGF alpha deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice. Cell. 1993 Apr 23;73(2):263–278. doi: 10.1016/0092-8674(93)90228-i. [DOI] [PubMed] [Google Scholar]
  123. Luo G., Niesel D. W., Shaban R. A., Grimm E. A., Klimpel G. R. Tumor necrosis factor alpha binding to bacteria: evidence for a high-affinity receptor and alteration of bacterial virulence properties. Infect Immun. 1993 Mar;61(3):830–835. doi: 10.1128/iai.61.3.830-835.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  124. Ma Y., Seiler K. P., Tai K. F., Yang L., Woods M., Weis J. J. Outer surface lipoproteins of Borrelia burgdorferi stimulate nitric oxide production by the cytokine-inducible pathway. Infect Immun. 1994 Sep;62(9):3663–3671. doi: 10.1128/iai.62.9.3663-3671.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  125. Mai U. E., Perez-Perez G. I., Wahl L. M., Wahl S. M., Blaser M. J., Smith P. D. Soluble surface proteins from Helicobacter pylori activate monocytes/macrophages by lipopolysaccharide-independent mechanism. J Clin Invest. 1991 Mar;87(3):894–900. doi: 10.1172/JCI115095. [DOI] [PMC free article] [PubMed] [Google Scholar]
  126. Mancuso G., Tomasello F., von Hunolstein C., Orefici G., Teti G. Induction of tumor necrosis factor alpha by the group- and type-specific polysaccharides from type III group B streptococci. Infect Immun. 1994 Jul;62(7):2748–2753. doi: 10.1128/iai.62.7.2748-2753.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  127. Mangan D. F., Wahl S. M., Sultzer B. M., Mergenhagen S. E. Stimulation of human monocytes by endotoxin-associated protein: inhibition of programmed cell death (apoptosis) and potential significance in adjuvanticity. Infect Immun. 1992 Apr;60(4):1684–1686. doi: 10.1128/iai.60.4.1684-1686.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  128. Manthey C. L., Qureshi N., Stütz P. L., Vogel S. N. Lipopolysaccharide antagonists block taxol-induced signaling in murine macrophages. J Exp Med. 1993 Aug 1;178(2):695–702. doi: 10.1084/jem.178.2.695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  129. Manthey C. L., Vogel S. N. Interactions of lipopolysaccharide with macrophages. Immunol Ser. 1994;60:63–81. [PubMed] [Google Scholar]
  130. Martin T. R., Mathison J. C., Tobias P. S., Letúrcq D. J., Moriarty A. M., Maunder R. J., Ulevitch R. J. Lipopolysaccharide binding protein enhances the responsiveness of alveolar macrophages to bacterial lipopolysaccharide. Implications for cytokine production in normal and injured lungs. J Clin Invest. 1992 Dec;90(6):2209–2219. doi: 10.1172/JCI116106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  131. Mathison J. C., Tobias P. S., Wolfson E., Ulevitch R. J. Plasma lipopolysaccharide (LPS)-binding protein. A key component in macrophage recognition of gram-negative LPS. J Immunol. 1992 Jul 1;149(1):200–206. [PubMed] [Google Scholar]
  132. Matsushita K., Nagaoka S., Arakaki R., Kawabata Y., Iki K., Kawagoe M., Takada H. Immunobiological activities of a 55-kilodalton cell surface protein of Prevotella intermedia ATCC 25611. Infect Immun. 1994 Jun;62(6):2459–2469. doi: 10.1128/iai.62.6.2459-2469.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  133. Mattsson E., Verhage L., Rollof J., Fleer A., Verhoef J., van Dijk H. Peptidoglycan and teichoic acid from Staphylococcus epidermidis stimulate human monocytes to release tumour necrosis factor-alpha, interleukin-1 beta and interleukin-6. FEMS Immunol Med Microbiol. 1993 Oct;7(3):281–287. doi: 10.1111/j.1574-695X.1993.tb00409.x. [DOI] [PubMed] [Google Scholar]
  134. McCormick B. A., Colgan S. P., Delp-Archer C., Miller S. I., Madara J. L. Salmonella typhimurium attachment to human intestinal epithelial monolayers: transcellular signalling to subepithelial neutrophils. J Cell Biol. 1993 Nov;123(4):895–907. doi: 10.1083/jcb.123.4.895. [DOI] [PMC free article] [PubMed] [Google Scholar]
  135. Miethke T., Wahl C., Heeg K., Echtenacher B., Krammer P. H., Wagner H. T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor. J Exp Med. 1992 Jan 1;175(1):91–98. doi: 10.1084/jem.175.1.91. [DOI] [PMC free article] [PubMed] [Google Scholar]
  136. Miller M. D., Krangel M. S. Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. Crit Rev Immunol. 1992;12(1-2):17–46. [PubMed] [Google Scholar]
  137. Mintz C. S., Miller R. D., Gutgsell N. S., Malek T. Legionella pneumophila protease inactivates interleukin-2 and cleaves CD4 on human T cells. Infect Immun. 1993 Aug;61(8):3416–3421. doi: 10.1128/iai.61.8.3416-3421.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  138. Moreno C., Mehlert A., Lamb J. The inhibitory effects of mycobacterial lipoarabinomannan and polysaccharides upon polyclonal and monoclonal human T cell proliferation. Clin Exp Immunol. 1988 Nov;74(2):206–210. [PMC free article] [PubMed] [Google Scholar]
  139. Moreno C., Taverne J., Mehlert A., Bate C. A., Brealey R. J., Meager A., Rook G. A., Playfair J. H. Lipoarabinomannan from Mycobacterium tuberculosis induces the production of tumour necrosis factor from human and murine macrophages. Clin Exp Immunol. 1989 May;76(2):240–245. [PMC free article] [PubMed] [Google Scholar]
  140. Mu H. H., Sewell W. A. Enhancement of interleukin-4 production by pertussis toxin. Infect Immun. 1993 Jul;61(7):2834–2840. doi: 10.1128/iai.61.7.2834-2840.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  141. Männel D. N., Falk W. Optimal induction of tumor necrosis factor production in human monocytes requires complete S-form lipopolysaccharide. Infect Immun. 1989 Jul;57(7):1953–1958. doi: 10.1128/iai.57.7.1953-1958.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  142. Mühlradt P. F., Frisch M. Purification and partial biochemical characterization of a Mycoplasma fermentans-derived substance that activates macrophages to release nitric oxide, tumor necrosis factor, and interleukin-6. Infect Immun. 1994 Sep;62(9):3801–3807. doi: 10.1128/iai.62.9.3801-3807.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  143. Müller-Alouf H., Alouf J. E., Gerlach D., Ozegowski J. H., Fitting C., Cavaillon J. M. Comparative study of cytokine release by human peripheral blood mononuclear cells stimulated with Streptococcus pyogenes superantigenic erythrogenic toxins, heat-killed streptococci, and lipopolysaccharide. Infect Immun. 1994 Nov;62(11):4915–4921. doi: 10.1128/iai.62.11.4915-4921.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  144. Naito Y., Ohno J., Takazoe I., Okuda K. The relationship between polysaccharide antigen and interleukin-1 beta producing activity in Porphyromonas gingivalis. Bull Tokyo Dent Coll. 1992 Nov;33(4):187–195. [PubMed] [Google Scholar]
  145. Norrby-Teglund A., Norgren M., Holm S. E., Andersson U., Andersson J. Similar cytokine induction profiles of a novel streptococcal exotoxin, MF, and pyrogenic exotoxins A and B. Infect Immun. 1994 Sep;62(9):3731–3738. doi: 10.1128/iai.62.9.3731-3738.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  146. Novogrodsky A., Vanichkin A., Patya M., Gazit A., Osherov N., Levitzki A. Prevention of lipopolysaccharide-induced lethal toxicity by tyrosine kinase inhibitors. Science. 1994 May 27;264(5163):1319–1322. doi: 10.1126/science.8191285. [DOI] [PubMed] [Google Scholar]
  147. O'Reilly T., Zak O. Enhancement of the effectiveness of antimicrobial therapy by muramyl peptide immunomodulators. Clin Infect Dis. 1992 May;14(5):1100–1109. doi: 10.1093/clinids/14.5.1100. [DOI] [PubMed] [Google Scholar]
  148. Ogawa T., Kusumoto Y., Uchida H., Nagashima S., Ogo H., Hamada S. Immunobiological activities of synthetic peptide segments of fimbrial protein from Porphyromonas gingivalis. Biochem Biophys Res Commun. 1991 Nov 14;180(3):1335–1341. doi: 10.1016/s0006-291x(05)81342-7. [DOI] [PubMed] [Google Scholar]
  149. Ogunniyi A. D., Manning P. A., Kotlarski I. A Salmonella enteritidis 11RX pilin induces strong T-lymphocyte responses. Infect Immun. 1994 Dec;62(12):5376–5383. doi: 10.1128/iai.62.12.5376-5383.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  150. Ohmori Y., Hamilton T. A. Ca2+ and calmodulin selectively regulate lipopolysaccharide-inducible cytokine mRNA expression in murine peritoneal macrophages. J Immunol. 1992 Jan 15;148(2):538–545. [PubMed] [Google Scholar]
  151. Onta T., Sashida M., Fujii N., Sugawara S., Rikiishi H., Kumagai K. Induction of acute arthritis in mice by peptidoglycan derived from gram-positive bacteria and its possible role in cytokine production. Microbiol Immunol. 1993;37(7):573–582. doi: 10.1111/j.1348-0421.1993.tb01679.x. [DOI] [PubMed] [Google Scholar]
  152. Otterlei M., Sundan A., Skjåk-Braek G., Ryan L., Smidsrød O., Espevik T. Similar mechanisms of action of defined polysaccharides and lipopolysaccharides: characterization of binding and tumor necrosis factor alpha induction. Infect Immun. 1993 May;61(5):1917–1925. doi: 10.1128/iai.61.5.1917-1925.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  153. Parmely M., Gale A., Clabaugh M., Horvat R., Zhou W. W. Proteolytic inactivation of cytokines by Pseudomonas aeruginosa. Infect Immun. 1990 Sep;58(9):3009–3014. doi: 10.1128/iai.58.9.3009-3014.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  154. Parrillo J. E. Pathogenetic mechanisms of septic shock. N Engl J Med. 1993 May 20;328(20):1471–1477. doi: 10.1056/NEJM199305203282008. [DOI] [PubMed] [Google Scholar]
  155. Poole S., Mussett M. V. The International Standard for Endotoxin: evaluation in an international collaborative study. J Biol Stand. 1989 Apr;17(2):161–171. doi: 10.1016/0092-1157(89)90006-1. [DOI] [PubMed] [Google Scholar]
  156. Porat R., Clark B. D., Wolff S. M., Dinarello C. A. Enhancement of growth of virulent strains of Escherichia coli by interleukin-1. Science. 1991 Oct 18;254(5030):430–432. doi: 10.1126/science.1833820. [DOI] [PubMed] [Google Scholar]
  157. Porat R., Yanoov M., Johns M. A., Shibolet S., Michalevicz R. Effects of endotoxin-associated protein on hematopoiesis. Infect Immun. 1992 May;60(5):1756–1760. doi: 10.1128/iai.60.5.1756-1760.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  158. Pothoulakis C., LaMont J. T., Eglow R., Gao N., Rubins J. B., Theoharides T. C., Dickey B. F. Characterization of rabbit ileal receptors for Clostridium difficile toxin A. Evidence for a receptor-coupled G protein. J Clin Invest. 1991 Jul;88(1):119–125. doi: 10.1172/JCI115267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  159. Proctor R. A., Will J. A., Burhop K. E., Raetz C. R. Protection of mice against lethal endotoxemia by a lipid A precursor. Infect Immun. 1986 Jun;52(3):905–907. doi: 10.1128/iai.52.3.905-907.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  160. Pugin J., Heumann I. D., Tomasz A., Kravchenko V. V., Akamatsu Y., Nishijima M., Glauser M. P., Tobias P. S., Ulevitch R. J. CD14 is a pattern recognition receptor. Immunity. 1994 Sep;1(6):509–516. doi: 10.1016/1074-7613(94)90093-0. [DOI] [PubMed] [Google Scholar]
  161. Pugin J., Schürer-Maly C. C., Leturcq D., Moriarty A., Ulevitch R. J., Tobias P. S. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):2744–2748. doi: 10.1073/pnas.90.7.2744. [DOI] [PMC free article] [PubMed] [Google Scholar]
  162. Raetz C. R., Ulevitch R. J., Wright S. D., Sibley C. H., Ding A., Nathan C. F. Gram-negative endotoxin: an extraordinary lipid with profound effects on eukaryotic signal transduction. FASEB J. 1991 Sep;5(12):2652–2660. doi: 10.1096/fasebj.5.12.1916089. [DOI] [PubMed] [Google Scholar]
  163. Ray C. A., Black R. A., Kronheim S. R., Greenstreet T. A., Sleath P. R., Salvesen G. S., Pickup D. J. Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1 beta converting enzyme. Cell. 1992 May 15;69(4):597–604. doi: 10.1016/0092-8674(92)90223-y. [DOI] [PubMed] [Google Scholar]
  164. Reddi K., Poole S., Nair S., Meghji S., Henderson B., Wilson M. Lipid A-associated proteins from periodontopathogenic bacteria induce interleukin-6 production by human gingival fibroblasts and monocytes. FEMS Immunol Med Microbiol. 1995 Apr;11(2):137–144. doi: 10.1111/j.1574-695X.1995.tb00100.x. [DOI] [PubMed] [Google Scholar]
  165. Reddi K., Wilson M., Poole S., Meghji S., Henderson B. Relative cytokine-stimulating activities of surface components of the oral periodontopathogenic bacterium Actinobacillus actinomycetemcomitans. Cytokine. 1995 Aug;7(6):534–541. doi: 10.1006/cyto.1995.0072. [DOI] [PubMed] [Google Scholar]
  166. Reimann T., Büscher D., Hipskind R. A., Krautwald S., Lohmann-Matthes M. L., Baccarini M. Lipopolysaccharide induces activation of the Raf-1/MAP kinase pathway. A putative role for Raf-1 in the induction of the IL-1 beta and the TNF-alpha genes. J Immunol. 1994 Dec 15;153(12):5740–5749. [PubMed] [Google Scholar]
  167. Retzlaff C., Yamamoto Y., Hoffman P. S., Friedman H., Klein T. W. Bacterial heat shock proteins directly induce cytokine mRNA and interleukin-1 secretion in macrophage cultures. Infect Immun. 1994 Dec;62(12):5689–5693. doi: 10.1128/iai.62.12.5689-5693.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  168. Riesenfeld-Orn I., Wolpe S., Garcia-Bustos J. F., Hoffmann M. K., Tuomanen E. Production of interleukin-1 but not tumor necrosis factor by human monocytes stimulated with pneumococcal cell surface components. Infect Immun. 1989 Jul;57(7):1890–1893. doi: 10.1128/iai.57.7.1890-1893.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  169. Rietschel E. T., Kirikae T., Schade F. U., Mamat U., Schmidt G., Loppnow H., Ulmer A. J., Zähringer U., Seydel U., Di Padova F. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J. 1994 Feb;8(2):217–225. doi: 10.1096/fasebj.8.2.8119492. [DOI] [PubMed] [Google Scholar]
  170. Roach T. I., Barton C. H., Chatterjee D., Blackwell J. M. Macrophage activation: lipoarabinomannan from avirulent and virulent strains of Mycobacterium tuberculosis differentially induces the early genes c-fos, KC, JE, and tumor necrosis factor-alpha. J Immunol. 1993 Mar 1;150(5):1886–1896. [PubMed] [Google Scholar]
  171. Roach T. I., Chatterjee D., Blackwell J. M. Induction of early-response genes KC and JE by mycobacterial lipoarabinomannans: regulation of KC expression in murine macrophages by Lsh/Ity/Bcg (candidate Nramp). Infect Immun. 1994 Apr;62(4):1176–1184. doi: 10.1128/iai.62.4.1176-1184.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  172. Roeder D. J., Lei M. G., Morrison D. C. Endotoxic-lipopolysaccharide-specific binding proteins on lymphoid cells of various animal species: association with endotoxin susceptibility. Infect Immun. 1989 Apr;57(4):1054–1058. doi: 10.1128/iai.57.4.1054-1058.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  173. Rogy M. A., Auffenberg T., Espat N. J., Philip R., Remick D., Wollenberg G. K., Copeland E. M., 3rd, Moldawer L. L. Human tumor necrosis factor receptor (p55) and interleukin 10 gene transfer in the mouse reduces mortality to lethal endotoxemia and also attenuates local inflammatory responses. J Exp Med. 1995 Jun 1;181(6):2289–2293. doi: 10.1084/jem.181.6.2289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  174. Rose J. R., Christ W. J., Bristol J. R., Kawata T., Rossignol D. P. Agonistic and antagonistic activities of bacterially derived Rhodobacter sphaeroides lipid A: comparison with activities of synthetic material of the proposed structure and analogs. Infect Immun. 1995 Mar;63(3):833–839. doi: 10.1128/iai.63.3.833-839.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  175. Rothe J., Lesslauer W., Lötscher H., Lang Y., Koebel P., Köntgen F., Althage A., Zinkernagel R., Steinmetz M., Bluethmann H. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature. 1993 Aug 26;364(6440):798–802. doi: 10.1038/364798a0. [DOI] [PubMed] [Google Scholar]
  176. Rutenfranz J., Plett R., Knauth P., Condon R., De Vol D., Fletcher N., Eickhoff S., Schmidt K. H., Donis R., Colquhoun W. P. Work at sea: a study of sleep, and of circadian rhythms in physiological and psychological functions, in watchkeepers on merchant vessels. II. Sleep duration, and subjective ratings of sleep quality. Int Arch Occup Environ Health. 1988;60(5):331–339. doi: 10.1007/BF00405666. [DOI] [PubMed] [Google Scholar]
  177. Sadlack B., Merz H., Schorle H., Schimpl A., Feller A. C., Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell. 1993 Oct 22;75(2):253–261. doi: 10.1016/0092-8674(93)80067-o. [DOI] [PubMed] [Google Scholar]
  178. Salman M., Deutsch I., Tarshis M., Naot Y., Rottem S. Membrane lipids of Mycoplasma fermentans. FEMS Microbiol Lett. 1994 Nov 1;123(3):255–260. doi: 10.1111/j.1574-6968.1994.tb07233.x. [DOI] [PubMed] [Google Scholar]
  179. Schlesinger L. S., Hull S. R., Kaufman T. M. Binding of the terminal mannosyl units of lipoarabinomannan from a virulent strain of Mycobacterium tuberculosis to human macrophages. J Immunol. 1994 Apr 15;152(8):4070–4079. [PubMed] [Google Scholar]
  180. Scholl P. R., Trede N., Chatila T. A., Geha R. S. Role of protein tyrosine phosphorylation in monokine induction by the staphylococcal superantigen toxic shock syndrome toxin-1. J Immunol. 1992 Apr 1;148(7):2237–2241. [PubMed] [Google Scholar]
  181. Schumann R. R., Leong S. R., Flaggs G. W., Gray P. W., Wright S. D., Mathison J. C., Tobias P. S., Ulevitch R. J. Structure and function of lipopolysaccharide binding protein. Science. 1990 Sep 21;249(4975):1429–1431. doi: 10.1126/science.2402637. [DOI] [PubMed] [Google Scholar]
  182. Schwab J. H. Phlogistic properties of peptidoglycan-polysaccharide polymers from cell walls of pathogenic and normal-flora bacteria which colonize humans. Infect Immun. 1993 Nov;61(11):4535–4539. doi: 10.1128/iai.61.11.4535-4539.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  183. Shapira L., Takashiba S., Champagne C., Amar S., Van Dyke T. E. Involvement of protein kinase C and protein tyrosine kinase in lipopolysaccharide-induced TNF-alpha and IL-1 beta production by human monocytes. J Immunol. 1994 Aug 15;153(4):1818–1824. [PubMed] [Google Scholar]
  184. Shimizu T., Iwamoto Y., Yanagihara Y., Kurimura M., Achiwa K. Mitogenic activity and the induction of tumor necrosis factor by lipopeptide analogs of the N-terminal part of lipoprotein in the outer membrane of Escherichia coli. Biol Pharm Bull. 1994 Jul;17(7):980–982. doi: 10.1248/bpb.17.980. [DOI] [PubMed] [Google Scholar]
  185. Shull M. M., Ormsby I., Kier A. B., Pawlowski S., Diebold R. J., Yin M., Allen R., Sidman C., Proetzel G., Calvin D. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature. 1992 Oct 22;359(6397):693–699. doi: 10.1038/359693a0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  186. Sibley L. D., Adams L. B., Krahenbuhl J. L. Inhibition of interferon-gamma-mediated activation in mouse macrophages treated with lipoarabinomannan. Clin Exp Immunol. 1990 Apr;80(1):141–148. doi: 10.1111/j.1365-2249.1990.tb06454.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  187. Sibley L. D., Hunter S. W., Brennan P. J., Krahenbuhl J. L. Mycobacterial lipoarabinomannan inhibits gamma interferon-mediated activation of macrophages. Infect Immun. 1988 May;56(5):1232–1236. doi: 10.1128/iai.56.5.1232-1236.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  188. Skidmore B. J., Morrison D. C., Chiller J. M., Weigle W. O. Immunologic properties of bacterial lipopolysaccharide (LPS). II. The unresponsiveness of C3H/HeJ Mouse spleen cells to LPS-induced mitogenesis is dependent on the method used to extract LPS. J Exp Med. 1975 Dec 1;142(6):1488–1508. doi: 10.1084/jem.142.6.1488. [DOI] [PMC free article] [PubMed] [Google Scholar]
  189. Soell M., Diab M., Haan-Archipoff G., Beretz A., Herbelin C., Poutrel B., Klein J. P. Capsular polysaccharide types 5 and 8 of Staphylococcus aureus bind specifically to human epithelial (KB) cells, endothelial cells, and monocytes and induce release of cytokines. Infect Immun. 1995 Apr;63(4):1380–1386. doi: 10.1128/iai.63.4.1380-1386.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  190. Soell M., Holveck F., Schöller M., Wachsmann R. D., Klein J. P. Binding of Streptococcus mutans SR protein to human monocytes: production of tumor necrosis factor, interleukin 1, and interleukin 6. Infect Immun. 1994 May;62(5):1805–1812. doi: 10.1128/iai.62.5.1805-1812.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  191. Soell M., Lett E., Holveck F., Schöller M., Wachsmann D., Klein J. P. Activation of human monocytes by streptococcal rhamnose glucose polymers is mediated by CD14 antigen, and mannan binding protein inhibits TNF-alpha release. J Immunol. 1995 Jan 15;154(2):851–860. [PubMed] [Google Scholar]
  192. Spriggs M. K., Hruby D. E., Maliszewski C. R., Pickup D. J., Sims J. E., Buller R. M., VanSlyke J. Vaccinia and cowpox viruses encode a novel secreted interleukin-1-binding protein. Cell. 1992 Oct 2;71(1):145–152. doi: 10.1016/0092-8674(92)90273-f. [DOI] [PubMed] [Google Scholar]
  193. Standiford T. J., Arenberg D. A., Danforth J. M., Kunkel S. L., VanOtteren G. M., Strieter R. M. Lipoteichoic acid induces secretion of interleukin-8 from human blood monocytes: a cellular and molecular analysis. Infect Immun. 1994 Jan;62(1):119–125. doi: 10.1128/iai.62.1.119-125.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  194. Stiles B. G., Bavari S., Krakauer T., Ulrich R. G. Toxicity of staphylococcal enterotoxins potentiated by lipopolysaccharide: major histocompatibility complex class II molecule dependency and cytokine release. Infect Immun. 1993 Dec;61(12):5333–5338. doi: 10.1128/iai.61.12.5333-5338.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  195. Stuart P. M., Woodward J. G. Yersinia enterocolitica produces superantigenic activity. J Immunol. 1992 Jan 1;148(1):225–233. [PubMed] [Google Scholar]
  196. Sultzer B. M., Craig J. P., Castagna R. The adjuvant effect of pertussis endotoxin protein in modulating the immune response to cholera toxoid in mice. Dev Biol Stand. 1985;61:225–232. [PubMed] [Google Scholar]
  197. Sultzer B. M., Goodman G. W. Endotoxin protein: a B-cell mitogen and polyclonal activator of C3H/HeJ lymphocytes. J Exp Med. 1976 Sep 1;144(3):821–827. doi: 10.1084/jem.144.3.821. [DOI] [PMC free article] [PubMed] [Google Scholar]
  198. Suttorp N., Fuhrmann M., Tannert-Otto S., Grimminger F., Bhadki S. Pore-forming bacterial toxins potently induce release of nitric oxide in porcine endothelial cells. J Exp Med. 1993 Jul 1;178(1):337–341. doi: 10.1084/jem.178.1.337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  199. Svanborg C., Agace W., Hedges S., Linder H., Svensson M. Bacterial adherence and epithelial cell cytokine production. Zentralbl Bakteriol. 1993 Apr;278(2-3):359–364. [PubMed] [Google Scholar]
  200. Tai K. F., Ma Y., Weis J. J. Normal human B lymphocytes and mononuclear cells respond to the mitogenic and cytokine-stimulatory activities of Borrelia burgdorferi and its lipoprotein OspA. Infect Immun. 1994 Feb;62(2):520–528. doi: 10.1128/iai.62.2.520-528.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  201. Takada H., Kawabata Y., Tamura M., Matsushita K., Igarashi H., Ohkuni H., Todome Y., Uchiyama T., Kotani S. Cytokine induction by extracellular products of oral viridans group streptococci. Infect Immun. 1993 Dec;61(12):5252–5260. doi: 10.1128/iai.61.12.5252-5260.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  202. Takahashi T., Nishihara T., Ishihara Y., Amano K., Shibuya N., Moro I., Koga T. Murine macrophage interleukin-1 release by capsularlike serotype-specific polysaccharide antigens of Actinobacillus actinomycetemcomitans. Infect Immun. 1991 Jan;59(1):18–23. doi: 10.1128/iai.59.1.18-23.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  203. Tanaka T., Akira S., Yoshida K., Umemoto M., Yoneda Y., Shirafuji N., Fujiwara H., Suematsu S., Yoshida N., Kishimoto T. Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages. Cell. 1995 Jan 27;80(2):353–361. doi: 10.1016/0092-8674(95)90418-2. [DOI] [PubMed] [Google Scholar]
  204. Taniguchi H., Sakano T., Hamasaki T., Kashiwa H., Ueda K. Effect of protein kinase C inhibitor (H-7) and calmodulin antagonist (W-7) on pertussis toxin-induced IL-1 production by human adherent monocytes. Comparison with lipopolysaccharide as a stimulator of IL-1 production. Immunology. 1989 Jun;67(2):210–215. [PMC free article] [PubMed] [Google Scholar]
  205. Taverne J. Transgenic mice in the study of cytokine function. Int J Exp Pathol. 1993 Dec;74(6):525–546. [PMC free article] [PubMed] [Google Scholar]
  206. Tesh V. L., Ramegowda B., Samuel J. E. Purified Shiga-like toxins induce expression of proinflammatory cytokines from murine peritoneal macrophages. Infect Immun. 1994 Nov;62(11):5085–5094. doi: 10.1128/iai.62.11.5085-5094.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  207. Timmerman C. P., Mattsson E., Martinez-Martinez L., De Graaf L., Van Strijp J. A., Verbrugh H. A., Verhoef J., Fleer A. Induction of release of tumor necrosis factor from human monocytes by staphylococci and staphylococcal peptidoglycans. Infect Immun. 1993 Oct;61(10):4167–4172. doi: 10.1128/iai.61.10.4167-4172.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  208. Tobias P. S., Soldau K., Ulevitch R. J. Identification of a lipid A binding site in the acute phase reactant lipopolysaccharide binding protein. J Biol Chem. 1989 Jun 25;264(18):10867–10871. [PubMed] [Google Scholar]
  209. Tobias P. S., Soldau K., Ulevitch R. J. Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum. J Exp Med. 1986 Sep 1;164(3):777–793. doi: 10.1084/jem.164.3.777. [DOI] [PMC free article] [PubMed] [Google Scholar]
  210. Tracey K. J., Cerami A. Tumor necrosis factor: an updated review of its biology. Crit Care Med. 1993 Oct;21(10 Suppl):S415–S422. [PubMed] [Google Scholar]
  211. Tsukada H., Kawamura I., Fujimura T., Igarashi K., Arakawa M., Mitsuyama M. Induction of macrophage interleukin-1 production by Listeria monocytogenes hemolysin. Cell Immunol. 1992 Mar;140(1):21–30. doi: 10.1016/0008-8749(92)90173-m. [DOI] [PubMed] [Google Scholar]
  212. Tsutsui O., Kokeguchi S., Matsumura T., Kato K. Relationship of the chemical structure and immunobiological activities of lipoteichoic acid from Streptococcus faecalis (Enterococcus hirae) ATCC 9790. FEMS Microbiol Immunol. 1991 Aug;3(4):211–218. doi: 10.1111/j.1574-6968.1991.tb04217.x. [DOI] [PubMed] [Google Scholar]
  213. Tufano M. A., Cipollaro de l'Ero G., Ianniello R., Galdiero M., Galdiero F. Protein A and other surface components of Staphylococcus aureus stimulate production of IL-1 alpha, IL-4, IL-6, TNF and IFN-gamma. Eur Cytokine Netw. 1991 Nov-Dec;2(5):361–366. [PubMed] [Google Scholar]
  214. Tufano M. A., Rossano F., Catalanotti P., Liguori G., Capasso C., Ceccarelli M. T., Marinelli P. Immunobiological activities of Helicobacter pylori porins. Infect Immun. 1994 Apr;62(4):1392–1399. doi: 10.1128/iai.62.4.1392-1399.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  215. Tufano M. A., Rossano F., Catalanotti P., Liguori G., Marinelli A., Baroni A., Marinelli P. Properties of Yersinia enterocolitica porins: interference with biological functions of phagocytes, nitric oxide production and selective cytokine release. Res Microbiol. 1994 May;145(4):297–307. doi: 10.1016/0923-2508(94)90185-6. [DOI] [PubMed] [Google Scholar]
  216. Ulevitch R. J. Recognition of bacterial endotoxins by receptor-dependent mechanisms. Adv Immunol. 1993;53:267–289. doi: 10.1016/s0065-2776(08)60502-7. [DOI] [PubMed] [Google Scholar]
  217. Ulevitch R. J., Tobias P. S. Recognition of endotoxin by cells leading to transmembrane signaling. Curr Opin Immunol. 1994 Feb;6(1):125–130. doi: 10.1016/0952-7915(94)90043-4. [DOI] [PubMed] [Google Scholar]
  218. Ulmer A. J., Feist W., Heine H., Kirikae T., Kirikae F., Kusumoto S., Kusama T., Brade H., Schade U., Rietschel E. T. Modulation of endotoxin-induced monokine release in human monocytes by lipid A partial structures that inhibit binding of 125I-lipopolysaccharide. Infect Immun. 1992 Dec;60(12):5145–5152. doi: 10.1128/iai.60.12.5145-5152.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  219. Wallis R. S., Paranjape R., Phillips M. Identification by two-dimensional gel electrophoresis of a 58-kilodalton tumor necrosis factor-inducing protein of Mycobacterium tuberculosis. Infect Immun. 1993 Feb;61(2):627–632. doi: 10.1128/iai.61.2.627-632.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  220. Walmrath D., Ghofrani H. A., Rosseau S., Schütte H., Cramer A., Kaddus W., Grimminger F., Bhakdi S., Seeger W. Endotoxin "priming" potentiates lung vascular abnormalities in response to Escherichia coli hemolysin: an example of synergism between endo- and exotoxin. J Exp Med. 1994 Oct 1;180(4):1437–1443. doi: 10.1084/jem.180.4.1437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  221. Weber G., Link F., Ferber E., Munder P. G., Zeitter D., Bartlett R. R., Nixdorff K. Differential modulation of the effects of lipopolysaccharide on macrophages by a major outer membrane protein of Proteus mirabilis. J Immunol. 1993 Jul 1;151(1):415–424. [PubMed] [Google Scholar]
  222. Weidemann B., Brade H., Rietschel E. T., Dziarski R., Bazil V., Kusumoto S., Flad H. D., Ulmer A. J. Soluble peptidoglycan-induced monokine production can be blocked by anti-CD14 monoclonal antibodies and by lipid A partial structures. Infect Immun. 1994 Nov;62(11):4709–4715. doi: 10.1128/iai.62.11.4709-4715.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  223. Weinstein S. L., Gold M. R., DeFranco A. L. Bacterial lipopolysaccharide stimulates protein tyrosine phosphorylation in macrophages. Proc Natl Acad Sci U S A. 1991 May 15;88(10):4148–4152. doi: 10.1073/pnas.88.10.4148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  224. Weis J. J., Ma Y., Erdile L. F. Biological activities of native and recombinant Borrelia burgdorferi outer surface protein A: dependence on lipid modification. Infect Immun. 1994 Oct;62(10):4632–4636. doi: 10.1128/iai.62.10.4632-4636.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  225. White J., Herman A., Pullen A. M., Kubo R., Kappler J. W., Marrack P. The V beta-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell. 1989 Jan 13;56(1):27–35. doi: 10.1016/0092-8674(89)90980-x. [DOI] [PubMed] [Google Scholar]
  226. Wilson K. P., Black J. A., Thomson J. A., Kim E. E., Griffith J. P., Navia M. A., Murcko M. A., Chambers S. P., Aldape R. A., Raybuck S. A. Structure and mechanism of interleukin-1 beta converting enzyme. Nature. 1994 Jul 28;370(6487):270–275. doi: 10.1038/370270a0. [DOI] [PubMed] [Google Scholar]
  227. Wright S. D. CD14 and innate recognition of bacteria. J Immunol. 1995 Jul 1;155(1):6–8. [PubMed] [Google Scholar]
  228. Wright S. D., Detmers P. A., Aida Y., Adamowski R., Anderson D. C., Chad Z., Kabbash L. G., Pabst M. J. CD18-deficient cells respond to lipopolysaccharide in vitro. J Immunol. 1990 Apr 1;144(7):2566–2571. [PubMed] [Google Scholar]
  229. Wright S. D., Jong M. T. Adhesion-promoting receptors on human macrophages recognize Escherichia coli by binding to lipopolysaccharide. J Exp Med. 1986 Dec 1;164(6):1876–1888. doi: 10.1084/jem.164.6.1876. [DOI] [PMC free article] [PubMed] [Google Scholar]
  230. Wright S. D., Ramos R. A., Tobias P. S., Ulevitch R. J., Mathison J. C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science. 1990 Sep 21;249(4975):1431–1433. doi: 10.1126/science.1698311. [DOI] [PubMed] [Google Scholar]
  231. Wright S. D., Tobias P. S., Ulevitch R. J., Ramos R. A. Lipopolysaccharide (LPS) binding protein opsonizes LPS-bearing particles for recognition by a novel receptor on macrophages. J Exp Med. 1989 Oct 1;170(4):1231–1241. doi: 10.1084/jem.170.4.1231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  232. Wurfel M. M., Hailman E., Wright S. D. Soluble CD14 acts as a shuttle in the neutralization of lipopolysaccharide (LPS) by LPS-binding protein and reconstituted high density lipoprotein. J Exp Med. 1995 May 1;181(5):1743–1754. doi: 10.1084/jem.181.5.1743. [DOI] [PMC free article] [PubMed] [Google Scholar]
  233. Wurfel M. M., Kunitake S. T., Lichenstein H., Kane J. P., Wright S. D. Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS. J Exp Med. 1994 Sep 1;180(3):1025–1035. doi: 10.1084/jem.180.3.1025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  234. Yamamoto Y., Okubo S., Klein T. W., Onozaki K., Saito T., Friedman H. Binding of Legionella pneumophila to macrophages increases cellular cytokine mRNA. Infect Immun. 1994 Sep;62(9):3947–3956. doi: 10.1128/iai.62.9.3947-3956.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  235. Yao L., Bengualid V., Lowy F. D., Gibbons J. J., Hatcher V. B., Berman J. W. Internalization of Staphylococcus aureus by endothelial cells induces cytokine gene expression. Infect Immun. 1995 May;63(5):1835–1839. doi: 10.1128/iai.63.5.1835-1839.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  236. Yoshikawa H., Kawamura I., Fujita M., Tsukada H., Arakawa M., Mitsuyama M. Membrane damage and interleukin-1 production in murine macrophages exposed to listeriolysin O. Infect Immun. 1993 Apr;61(4):1334–1339. doi: 10.1128/iai.61.4.1334-1339.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  237. Zhang X., Morrison D. C. Pertussis toxin-sensitive factor differentially regulates lipopolysaccharide-induced tumor necrosis factor-alpha and nitric oxide production in mouse peritoneal macrophages. J Immunol. 1993 Feb 1;150(3):1011–1018. [PubMed] [Google Scholar]
  238. Zhang Y., Broser M., Cohen H., Bodkin M., Law K., Reibman J., Rom W. N. Enhanced interleukin-8 release and gene expression in macrophages after exposure to Mycobacterium tuberculosis and its components. J Clin Invest. 1995 Feb;95(2):586–592. doi: 10.1172/JCI117702. [DOI] [PMC free article] [PubMed] [Google Scholar]
  239. Zhang Y., Broser M., Rom W. N. Activation of the interleukin 6 gene by Mycobacterium tuberculosis or lipopolysaccharide is mediated by nuclear factors NF-IL6 and NF-kappa B. Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2225–2229. doi: 10.1073/pnas.91.6.2225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  240. Ziegler-Heitbrock H. W., Ulevitch R. J. CD14: cell surface receptor and differentiation marker. Immunol Today. 1993 Mar;14(3):121–125. doi: 10.1016/0167-5699(93)90212-4. [DOI] [PubMed] [Google Scholar]
  241. de Jong D. M., Pate J. L., Kirkland T. N., Taylor C. E., Baker P. J., Takayama K. Lipopolysaccharidelike immunological properties of cell wall glycoproteins isolated from Cytophaga johnsonae. Infect Immun. 1991 Aug;59(8):2631–2637. doi: 10.1128/iai.59.8.2631-2637.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Microbiological Reviews are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES